Re: MNKD NYC Presentation at 12:05 pm ET Today
The presentation yesterday was like one long sentence, without periods. Still, Mike C. did enlarge the scope of what a future MNKD could look like. He focused on recently released Afrezza studies (i.e. more time in narrower blood sugar ranges) and its growing prescriptions, the Techosphere molecule pipeline, Afrezza international marketing deals (given regulatory marketing approval) for Brazil (shipped this month), and hopefully, later approval with India, Australia, etc. The Technophere pipeline needs to continue to stay in focus, as it will also be a key to future revenues. JMHO.